Global Humanized Mice Model Market
Global Humanized Mice Model Market was valued at USD 78.3 million in 2020 and is expected to reach at USD 138.23 million by 2030 at a CAGR 9.8% from 2020-2030.
Humanized Mice Model is a mouse which possesses functioning human genes, tissues, cells, and organs in case of biological & medical research for human therapeutics. These models are used to model the human immune system in scenarios of health & pathology.
Market Drivers
The increase in demand for more effective screening of new drug candidates discovered by the healthcare sector to treat number of chronic diseases including cardiovascular diseases, diabetes, and cancers, along with an emergence of new players due to the increase in demand for better mouse models which are capable of overcoming the limitations of xenograft models. These factors are expected to boost the global humanized mice model market over the forecast period.
Furthermore, rise in research and development activities carried out by pharmaceutical and biotechnology companies, continuous support and initiatives from government and private sectors for research on mouse models will positively influence the growth of global humanized mice model market throughout the forecast period. In addition, the increase in production of monoclonal antibodies as well as improvement of healthcare in developing countries
Market Restraints
Stringent rules & regulations for ethical use of animals & costly procedures for maintenance of animal housing are the major restraints which are expected to hamper the global humanized mice model market over the forecast period.
Market Segmentation
The Global Humanized Mice Model Market is segmented into type such as Cell-based Humanized Mouse Model (CD34, PBMC, BLT), and Genetic Humanized Mouse Model, by application such as Immunology & Infectious Diseases, Neuroscience, Oncology, Hematopoiesis, Toxicology, and Others. Further, market is segmented into end user such as Contract Research Organizations (CROs), Pharmaceutical & Biotechnology Companies, and Academic & Research Institutes.
Regional Analysis
The Global Humanized Mice Model Market is segmented into five regions such as North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. The North America is the leading humanized mice model market is anticipated to account for the largest market share of the market in the year 2020. Due to the increase in biomedical research, preclinical activities by Contract Research Organizations and pharmaceutical research & development, continued & responsible use of animals ensured by animal care organizations, the rise in monoclonal antibody production in the United States along with growing stem cell research as well as government support for the development of protein drugs in this region.
Key Players
Various key players are listed in this report such as The Jackson Laboratory, Trans Genic, Inc., Axenis S.A.S, Ingenious Targeting Laboratory, Vitalstar Biotechnology Co., Ltd., Humurine Technologies, Harbour Antibodies BV, Genoway S.A., Horizon Discovery Group PLC, Taconic Biosciences, Inc., etc.
Market Taxonomy
By Type
By Application
By End User
By Region
Key Questions Addressed by the Report
Global Humanized Mice Model Market TOC
1 Introduction
1.1 Objective of the Study
1.2 Market definition
1.3 Market Scope
2 Research Methodology
2.1 Data Mining
2.2 Validation
2.3 Primary Interviews
2.4 List of Data Sources
3 Executive Summary
4 Global Humanized Mice Model Market Outlook
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
5 Global Humanized Mice Model Market, By Type
5.1 Y-o-Y Growth Comparison, By Type
5.2 Global Humanized Mice Model Market Share Analysis, By Type
5.3 Global Humanized Mice Model Market Size and Forecast, By Type
5.3.1 Cell-based Humanized Mouse Model
5.3.1.1. CD34
5.3.1.2. PBMC
5.3.1.3. BLT
5.3.2. Genetic Humanized Mouse Model
6 Global Humanized Mice Model Market, By Application
6.1 Y-o-Y Growth Comparison, By Application
6.2 Global Humanized Mice Model Market Share Analysis, By Application
6.3 Global Humanized Mice Model Market Size and Forecast, By Application
6.3.1 Immunology & Infectious Diseases
6.3.2 Neuroscience
6.3.3 Oncology
6.3.4 Hematopoiesis
6.3.5. Toxicology
6.3.6. Other
7 Global Humanized Mice Model Market, By End User
7.1 Y-o-Y Growth Comparison, By End User
7.2 Global Humanized Mice Model Market Share Analysis, By End User
7.3 Global Humanized Mice Model Market Size and Forecast, By End User
7.3. 1 Contract Research Organizations (CROs)
7.3.2. Pharmaceutical & Biotechnology Companies
7.3.3. Academic and Research Institutes
8 Global Humanized Mice Model Market, By Region
8.1 Global Humanized Mice Model Market Share Analysis, By Region
8.2 Global Humanized Mice Model Market Share Analysis, By Region
8.3 Global Humanized Mice Model Market Size and Forecast, By Region
9 North America Humanized Mice Model Market Analysis and Forecast (2020-2030)
9.1 Introduction
9.2 North America Humanized Mice Model Market Share Analysis, By Type
9.3 North America Humanized Mice Model Market Size and Forecast, By Application
9.4 North America Humanized Mice Model Market Size and Forecast, By End User
9.5 North America Humanized Mice Model Market Size and Forecast, By Country
9.5.1 U.S.
9.5.2 Canada
9.5.3 Mexico
10 Europe Humanized Mice Model Market Analysis and Forecast (2020-2030)
10.1 Introduction
10.2 Europe Humanized Mice Model Market Share Analysis, By Type
10.3 Europe Humanized Mice Model Market Size and Forecast, By Application
10.4 Europe Humanized Mice Model Market Size and Forecast, By End User
10.5 Europe Humanized Mice Model Market Size and Forecast, By Country
10.5.1 Germany
10.5.2 France
10.5.3 UK
10.54. Rest of Europe
11 Asia Pacific Humanized Mice Model Market Analysis and Forecast (2020-2030)
11.1 Introduction
11.2 Asia Pacific Humanized Mice Model Market Share Analysis, By Type
11.3 Asia Pacific Humanized Mice Model Market Size and Forecast, By Application
11.4 Asia Pacific Humanized Mice Model Market Size and Forecast, By End User
11.5 Asia Pacific Humanized Mice Model Market Size and Forecast, By Country
11.5.1 China
11.5.2 Japan
11.5.3 India
11.5.4. Rest of Asia Pacific
12 Latin America Humanized Mice Model Market Analysis and Forecast (2020-2030)
12.1 Introduction
12.2 Latin America Humanized Mice Model Market Share Analysis, By Type
12.3 Latin America Humanized Mice Model Market Size and Forecast, By Application
12.4 Latin America Humanized Mice Model Market Size and Forecast, By End User
12.5 Latin America Humanized Mice Model Market Size and Forecast, Country
13 Middle East Humanized Mice Model Market Analysis and Forecast (2020-2030)
13.1 Introduction
13.2 Middle East Humanized Mice Model Market Share Analysis, By Type
13.3 Middle East Humanized Mice Model Market Size and Forecast, By Application
13.4 Middle East Humanized Mice Model Market Size and Forecast, By End User
13.5 Middle East Humanized Mice Model Market Size and Forecast, By Country
14 Competitive Analysis
14.1 Competition Dashboard
14.2 Market share Analysis of Top Vendors
14.3 Key Development Strategies
15 Company Profiles
15.1 The Jackson Laboratory
15.1.1 Overview
15.1.2 Offerings
15.1.3 Key Financials
15.1.4 Business Segment & Geographic Overview
15.1.5 Key Market Developments
15.1.6 Key Strategies
15.2. Trans Genic, Inc
15.2.1 Overview
15.2.2 Offerings
15.2.3 Key Financials
15.2.4 Business Segment & Geographic Overview
15.2.5 Key Market Developments
15.2.6 Key Strategies
15.3. Axenis S.A.S
15.3.1 Overview
15.3.2 Offerings
15.3.3 Key Financials
15.3.4 Business Segment & Geographic Overview
15.3.5 Key Market Developments
15.3.6 Key Strategies
15.4 Ingenious Targeting Laboratory
15.4.1 Overview
15.4.2 Offerings
15.4.3 Key Financials
15.4.4 Business Segment & Geographic Overview
15.4.5 Key Market Developments
15.4.6 Key Strategies
15.5 Vitalstar Biotechnology Co., Ltd
15.5.1 Overview
15.5.2 Offerings
15.5.3 Key Financials
15.5.4 Business Segment & Geographic Overview
15.5.5 Key Market Developments
15.5.6 Key Strategies
15.6 Humurine Technologies
15.6.1 Overview
15.6.2 Offerings
15.6.3 Key Financials
15.6.4 Business Segment & Geographic Overview
15.6.5 Key Market Developments
15.6.6 Key Strategies
15.7 Harbour Antibodies BV
15.7.1 Overview
15.7.2 Offerings
15.7.3 Key Financials
15.7.4 Business Segment & Geographic Overview
15.7.5 Key Market Developments
15.7.6 Key Strategies
15.8 Genoway S.A
15.8.1 Overview
15.8.2 Offerings
15.8.3 Key Financials
15.8.4 Business Segment & Geographic Overview
15.8.5 Key Market Developments
15.8.6 Key Strategies
15.9 Horizon Discovery Group PLC
15.9.1 Overview
15.9.2 Offerings
15.9.3 Key Financials
15.9.4 Business Segment & Geographic Overview
15.9.5 Key Market Developments
15.9.6 Key Strategies
15.10 Taconic Biosciences, Inc
15.10.1 Overview
15.10.2 Offerings
15.10.3 Key Financials
15.10.4 Business Segment & Geographic Overview
15.10.5 Key Market Developments
15.10.6 Key Strategies
